Answers are grounded in this paper and cite their sources.
Background Extended spectrum beta lactamase (ESBL) producing bacteria, significantly lower the effectiveness of treatment of neonatal sepsis which accounts for 15-20% of death globally. There is limited data on prevalence and determinants of associated factors, hence highlighting the need of conducting this study at university of Dodoma teaching hospitals in Dodoma. Methods A cross-sectional study enrolled 300 term neonates with sign and symptoms of sepsis treated at Benjamin Mkapa and Dodoma Regional Referral Hospital. Data collection began from 01/09/2024 to 30/06/2025 and medical records were accessed on the same dates. A consecutive sampling was conducted until sample size was reached. Data was collected through structured questionnaires. Double disc synergistic test was done for detection of ESBL producing bacterial isolates and antimicrobial susceptibility test conducted as per CLSI.Data analysis was done using SPSS version 26. Descriptive statistics was computed and logistic regression models were used to identify factors associated with ESBL production. A p value<0.05 and 95% CI was considered statistically significant. The study protocol was reviewed and approved by the Institution Research Review Ethical Committee (IRREC) at the University of Dodoma (UDOM). The approval number to conduct this research at Benjamin Mkapa Hospital was AB.150/293/01/"A"/241 and Dodoma Regional Referral Hospital was PB.22/1307/02/86. Written informed consent to participate was obtained from the parent or legal guardian of each neonate prior to enrollment. Parents/guardians received a full explanation of the study aims, procedures, potential benefits and risks, and the voluntary nature of participation. They were informed that refusal or withdrawal at any time would not affect the clinical care their child received. Study data and bacterial isolates were anonymized and stored securely; only the study team had access to identifiable information. Permission to publish anonymized group-level results was obtained as part of the consent process. Clinical trial number: not applicable Results Among 300 neonates, 114/300(38%) yielded culture positive and 49/114 (43%) were gram negative. ESBL producing bacteria accounted for 14.7%(44/300) and significant associated factors were caesarean delivery [p value=0.005, AOR= 5.22, 95% CI(1.66- 16.40)], PROM [p value<0.001, AOR=21.54, 95% CI(5.53- 83.97)], maternal febrile condition [p value<0.001, AOR= 20.71, 95% CI(5.17- 82.89)], elevated CRP (10-49mg/L) [p value=0.033, AOR=4.97, 95% CI(1.14- 21.68)], and invasive procedure [p value=0.046, AOR=3.10, 1.02- 9.38)].The common isolate were Klebsiella aeruginosa 15/49(30.6%) and Escherichia coli 12/49(24.5%) with meropenem sensitivity of 93.3% and 91.7%, resistance to Ampicillin at 93% and 100%, Ceftriaxone resistance 73% and 66.7% respectively. Conclusion The prevalence of ESBL was found to be considerable burden in term neonate with sepsis. Neonates born through caesarean section, with maternal febrile conditions, and PROM should be considered high risk of acquiring ESBL. There was multiple resistance to first- and second-line antibiotics as recommended by WHO in treatment of neonatal sepsis hence further review needed on antibiotic of choice used according WHO and Tanzania standard treatment guideline. Extended-spectrum beta-lactamase , resistance , term neonates , neonatal sepsis , prevalence, and associated factors.
No takes yet. Share an insight, caveat, or question.
Idinga et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: